ASTM E2882-12 - 1.8.2012
 
Significance and Use

4.1 An understanding of clandestine laboratory synthetic routes and the techniques used in the analysis of related samples is considered to be fundamental to the interpretation and reporting of results. This understanding assures that results and conclusions from methods are reliable and analytical schemes are fit for purpose.

4.2 The qualitative and quantitative analyses of clandestine laboratory evidence can require different approaches relative to routine seized drug analyses. Analysts shall understand the limitations of the procedures used in their qualitative and quantitative analyses. These include such factors as method selectivity, uncertainty, and the basis for inferences from a sample(s) to a population.

4.3 Laboratory management shall ensure that clandestine laboratory synthesis and analysis training be provided through relevant procedures, literature, and practical experience. Practical experience typically includes production, sampling and analysis of clandestine laboratory training samples.

4.4 Laboratory management shall ensure that chemical safety and hygiene plans address and mitigate hazards associated with clandestine laboratory evidence.

4.5 Laboratory management shall consider customer/local requirements which influence the application of these recommendations.

 
1. Scope

1.1 This guide is intended to be used in conjunction with the general requirements for the analysis of seized drugs (Practices E2326, E2327, E2329, and E2549; Guides E2548 and E2329). This guide provides guidance on the chemical analysis of items and samples related to suspected clandestine drug laboratories. It does not address scene attendance or scene processing. This document provides general guidance for the analysis of clandestine laboratory evidence and is not a substitute for detailed and validated laboratory policies and technical procedures.

1.2 This guide does not replace knowledge, skill, ability, experience, education, or training and should be used in conjunction with professional judgment.

 
2. Referenced Documents

E2548-16

Standard Guide for Sampling Seized Drugs for Qualitative and Quantitative Analysis

E2549-14

Standard Practice for Validation of Seized-Drug Analytical Methods (Withdrawn 2023)

F2725-19

Standard Guide for European Union's Registration, Evaluation, and Authorization of Chemicals (REACH) Supply Chain Information Exchange

E2329-17

Standard Practice for Identification of Seized Drugs

E2363-23

Standard Terminology Relating to Manufacturing of Pharmaceutical and Biopharmaceutical Products in the Pharmaceutical and Biopharmaceutical Industry

D6161-19

Standard Terminology Used for Microfiltration, Ultrafiltration, Nanofiltration, and Reverse Osmosis Membrane Processes

E1605-22

Standard Terminology Relating to Lead in Buildings

E2326-14

Standard Practice for Education and Training of Seized-Drug Analysts (Withdrawn 2023)

E2327-15

Standard Practice for Quality Assurance of Laboratories Performing Seized-Drug Analysis